-
Health Care Commission: 18 new confirmed cases are imported from abroad
Time of Update: 2021-02-24
From 0:24 p.m. on February 18, 31 provinces (autonomous regions, municipalities directly under the Central Government) and the Xinjiang Production and Construction Corps reported 10 new confirmed cases, all of which were imported from abroad (7 in Shanghai, 2 in Tianjin and 1 in Hunan); 46 new cases were cured and discharged from hospital on the same day, 406 close contacts were released from medical observation, and 2 cases of severe illness were reduced from the previous day.
-
7618 pharmaceutical companies were named! If you don't do it again, the winning product will be removed from the network...
Time of Update: 2021-02-24
Pharmaceutical Network February 8 - Zhejiang Pharmaceutical Procurement Center recently issued a notice, named 7618 enterprises, urging the pharmaceutical enterprises as soon as possible to submit the
-
Global Pharmaceutical CEO Compensation PK: AZ annual salary of 140 million yuan Roche down salary Novar3 sad year-end award
Time of Update: 2021-02-24
02 Roche/Novarter CEO's annual salary doubles, a year-end award for the base salary 2020 new crown pandemic raging around the world, seriously affecting global economic growth, most companies are struggling, layoffs and pay cuts.
-
How to solve the primary problem of medical reform? The maximum price is the key!
Time of Update: 2021-02-24
Next, led by the Health Insurance Bureau to monitor drugs, for example, after a year of monitoring, drug A most hospital procurement price of 8 yuan / branch, the market supply is adequate, the operation of enterprises is good, although there are individual enterprises have a loss, because of the enterprise's low level of science and technology, poor management capacity, at the same time, found that some hospitals still have doctors to take kickbacks.
-
Supplies overhaul the Municipal Commission for Discipline Inspection supervision assigned to 12 groups of full-process supervision
Time of Update: 2021-02-24
For pharmaceutical enterprises rated as "particularly serious", in addition to warning and warning of risks, the enterprise shall be restricted or suspended all drugs and medical supplies hanging network, bidding or distribution qualifications, restrictions or suspension period according to the pharmaceutical enterprise credit repair behavior and results of timely adjustment.
-
A batch of medical devices named by the State Drug Administration (attached list)
Time of Update: 2021-02-24
(vii) Cardiovascular optically relevant fault imaging equipment and accessories: The product consists of a host and disposable vascular imaging catheter, expected to be used for coronary artery imaging, for clinical patients who need intra-cavity interventional treatment, especially in stent implantation.
-
Li Keqiang Signs State Council Order to Publish Regulations on Supervision and Administration of the Use of Medical Security Funds
Time of Update: 2021-02-24
Decree no. 735 of the State Council of the People's Republic of China on the Supervision and Administration of the Use of Medical Security Funds has been adopted by the 117th Executive Meeting of the
-
2020 Drug Quality Announcement Large Inventory
Time of Update: 2021-02-24
The chart above shows the ranking of more than 6 batches (including 6 batches) the top five non-conforming test items for Chinese herbal medicine/Chinese medicine tablets are characteristics (365 batches), content determination (236 batches), identification (88 batches), total ash (62 batches), inspection (39 batches).
-
Chen Wei team's vaccine release phase three data experts: suitable for rapid mass vaccination
Time of Update: 2021-02-24
the Ad5-nCoV vaccine developed by Chen Wei's team is the world's first new crown vaccine to enter the clinical research phase, and is currently one of the only single-shot vaccines in the world that has released phase III trial data, several experts told global Times reporters, the effectiveness of the vaccine data is very good, and single-shot vaccination means that large-scale rapid vaccination of the population, the overall social epidemic prevention strategy is of great importance.
-
FDA accelerates approval of innovative PI3K inhibitors to treat lymphoma
Time of Update: 2021-02-24
in patients with marginal lymphoma (MZL), Ukoniq achieved an objective remission rate (ORR) of 49%, including a full remission rate of 16%, and the medium remission duration (DOR) had not yet been achieved.
-
Biosynthic drug Baiotai "Golimu monoantigen" initiates Phase III clinical
Time of Update: 2021-02-24
From insight database () Golimu monoantigen is a TNF-α monoantigen developed by Johnson and Johnson and Synglia, which was approved by the U.S. FDA in 2013 for the treatment of moderate to severe active rheumatoid arthritis (RA).
-
Dongsian "Mendong Insulin 30" listing application was accepted by the third domestic
Time of Update: 2021-02-24
according to insight database (), in addition to the approved Ganli Pharmaceuticals, Zhuhai Federation has also submitted a listing application, Dongsan this time listed as the third domestic paragraph.
-
Researchers have published the latest results in the development of new crown drugs in Science
Time of Update: 2021-02-23
The study reported a series of highly active new structural new coronavirus Mpro small molecule inhibitors, and elaborated the agents and antiviral effects of these inhibitors at the molecular, cell and animal levels, confirming the potential of these compounds to develop anti-SARS-CoV-2 virus drugs in terms of pharmacological properties and safety.
-
Is there allergic rhinitis to get a new crown vaccine? Beijing CDC replied
Time of Update: 2021-02-23
: According to the previous clinical trial of the new coronavirus inactivated vaccine, only one dose of inactivated vaccine can not produce the expected immune effect.
-
Health Care Commission: 19 new confirmed cases of 8 cases are imported from abroad
Time of Update: 2021-02-23
From 000 to 2400 hours on February 19, 31 provinces (autonomous regions, municipalities directly under the Central Government) and the Xinjiang Production and Construction Corps reported 8 new confir
-
Healthy people try poison! Britain's new crown "human challenge trial" behind
Time of Update: 2021-02-23
, Feb. 20 (Xinhua) -- After about a year of controversy, the world's first "human challenge trial" of the new coronavirus has finally landed in the United Kingdom, has been recognized by the country's ethics agencies.
-
The first case of human infection with H5N8 avian influenza has been detected in Russia
Time of Update: 2021-02-23
BEIJING, Feb. 21 (Xinhua) -- Researchers at russia's Vector Science Center have found the first laboratory-confirmed case of human infection with H5N8 avian influenza, said Anna Popova, head of the Russian Federation's Consumer Protection and Public Interest Supervision Agency.
-
Russian scientists have found out for the first time the cause of speech disorders in people with autism
Time of Update: 2021-02-23
, Feb. 17 (Reporter Dong Yingxuan) Moscow State University of Psychology and Education has discovered for the first time in the world the causes of speech disorders in people with autism associated with the work of the auditory cortical layer of the brain.
-
The results of phase III clinical trials of Chen Wei's team's new crown vaccine were announced
Time of Update: 2021-02-23
On the evening of February 8th, Yan News () learned from authoritative sources that the mid-stage analysis of China's recombinant new crown vaccine (adenovirus vector) Phase III clinical trial, jointly developed by the Chen Wei team of the Chinese Academy of Engineering and Concino Bio-Co., Ltd., was successfully completed.
-
Cop: Is it feasible to mix different new crown vaccines?
Time of Update: 2021-02-23
clinical trial led by researchers at oxford University will explore the feasibility of using different new crown vaccines in the first and second doses of "enhanced needles," the University of Oxford said in a press release.